Low dose
Sponsors
The First Affiliated Hospital of Anhui Medical University, Shulan (Hangzhou) Hospital, University of Missouri-Columbia, Boehringer Ingelheim, Xiangbei Welman Pharmaceutical Co., Ltd
Conditions
Acute Myocardial InfarctionApnea of PrematurityBioavailabilityChronic Spinal Cord InjuryChronic hepatitis BColitis, UlcerativeDomperidone OverdoseElectric Stimulation
Early Phase 1
A Single-Center, Open-label, Single-Arm, Dose Escalation and Dose Extension Investigator-Initiated Study (IIT) to Evaluate the Safety, Efficacy and Pharmacokinetic of EPI-001 Injection for the Treatment of Heterozygous Familial Hypercholesterolemia (HeFH)
Active, not recruitingChiCTR2400081208
Start: 2024-02-27Updated: 2024-03-04
A study on the safety, tolerance, pharmacokinetics and pharmacodynamics of EPI-003T injection in the treatment of chronic hepatitis B subjects who have been treated with nucleoside (acid) analogues
Active, not recruitingChiCTR2500110861
Start: 2025-10-22Updated: 2025-10-27
Phase 1
A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults
CompletedNCT00549523
Start: 2008-04-30End: 2012-01-31Updated: 2016-10-10
Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers
CompletedNCT01371006
Start: 2011-06-30Updated: 2015-08-03
Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults
CompletedNCT04439695
Start: 2020-06-25End: 2021-07-28Updated: 2021-09-16
Salmonella Vaccine Immunogenicity and Safety (SaVIS) Study
Active, not recruitingPACTR202310834458532
Start: 2024-01-16Target: 120Updated: 2026-01-27
Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.
Active, not recruitingNCT06905496
Start: 2024-06-03End: 2026-03-01Updated: 2025-04-01
Phase 2
Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
SuspendedNCT01601093
Start: 2011-11-30End: 2022-12-15Target: 288Updated: 2019-07-05
A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
CompletedNCT02493712
Start: 2016-01-31End: 2019-04-30Updated: 2021-10-26
Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction
CompletedNCT05485818
Start: 2020-11-23End: 2021-11-18Updated: 2022-08-03
A study to expand safety and immunogenicity data with the second generation of the Shigella bioconjugate tetravalent (Shigella4V2) in 9-month-old Kenyan infants.
Active, not recruitingPACTR202408653853505
Start: 2025-02-17Target: 110Updated: 2026-01-27
Phase 4
Unknown Phase
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
CompletedNCT04074616
Start: 2019-11-19End: 2023-04-20Updated: 2024-10-15
High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety
RecruitingNCT05158413
Start: 2022-03-31End: 2025-06-30Target: 40Updated: 2024-03-20
Food Supplement Effect on Overweight or Moderate Obesity
CompletedNCT05178667
Start: 2022-01-06End: 2022-10-31Updated: 2022-12-16
Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention
NCT05235360
Start: 2022-02-14End: 2023-07-31Target: 192Updated: 2022-02-28
Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)
CompletedNCT06214338
Start: 2024-02-12End: 2024-04-15Updated: 2024-05-20
ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
RecruitingNCT06264622
Start: 2024-02-26End: 2024-12-31Target: 180Updated: 2024-02-20
Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.
Active, not recruitingNCT06397612
Start: 2023-12-01End: 2026-08-28Target: 24Updated: 2026-03-17